Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


28.08.2017

1 AJNR Am J Neuroradiol
4 Am J Clin Oncol
1 Arch Pathol Lab Med
1 Br J Cancer
1 Br J Neurosurg
1 Cancer
1 Curr Treat Options Neurol
1 Eur J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Neurochem
7 J Neurooncol
4 J Neurosurg
1 J Nucl Med
1 JAMA
4 Neuro Oncol
8 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. FANG S, Liang J, Qian T, Wang Y, et al
    Anatomic Location of Tumor Predicts the Accuracy of Motor Function Localization in Diffuse Lower-Grade Gliomas Involving the Hand Knob Area.
    AJNR Am J Neuroradiol. 2017 Aug 24. doi: 10.3174/ajnr.A5342.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  2. BURRI SH, Gondi V, Brown PD, Mehta MP, et al
    The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.
    Am J Clin Oncol. 2017 Aug 24. doi: 10.1097/COC.0000000000000395.
    PubMed     Text format     Abstract available

  3. ELLSWORTH S, Ye X, Grossman SA
    Clinical, Radiographic, and Pathologic Findings in Patients Undergoing Reoperation Following Radiation Therapy and Temozolomide for Newly Diagnosed Glioblastoma.
    Am J Clin Oncol. 2017;40:219-222.
    PubMed     Text format     Abstract available

  4. BOXERMAN JL, Ellingson BM, Jeyapalan S, Elinzano H, et al
    Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
    Am J Clin Oncol. 2017;40:228-234.
    PubMed     Text format     Abstract available

  5. GHOSE A, Guha G, Kundu R, Tew J, et al
    CNS Hemangiopericytoma: A Systematic Review of 523 Patients.
    Am J Clin Oncol. 2017;40:223-227.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  6. CHANDRAMOHAN V, Bryant JD, Piao H, Keir ST, et al
    Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.
    Arch Pathol Lab Med. 2017 Aug 22. doi: 10.5858/arpa.2016-0580.
    PubMed     Text format     Abstract available


    Br J Cancer

  7. ITO S, Koso H, Sakamoto K, Watanabe S, et al
    RNA helicase DHX15 acts as a tumour suppressor in glioma.
    Br J Cancer. 2017 Aug 22. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Br J Neurosurg

  8. LOH D, Hogg F, Edwards P, MacColl J, et al
    Two-year experience of multi-disciplinary team (MDT) outcomes for brain metastases in a tertiary neuro-oncology centre.
    Br J Neurosurg. 2017 Aug 24:1-8. doi: 10.1080/02688697.2017.1368449.
    PubMed     Text format     Abstract available


    Cancer

  9. JOHNSON DB, Sullivan RJ, Menzies AM
    Immune checkpoint inhibitors in challenging populations.
    Cancer. 2017;123:1904-1911.
    PubMed     Text format     Abstract available


    Curr Treat Options Neurol

  10. CASTELLANO A, Cirillo S, Bello L, Riva M, et al
    Functional MRI for Surgery of Gliomas.
    Curr Treat Options Neurol. 2017;19:34.
    PubMed     Text format     Abstract available


    Eur J Cancer

  11. BLANK CU, Larkin J, Arance AM, Hauschild A, et al
    Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis.
    Eur J Cancer. 2017;79:176-184.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  12. XIE Y, Bentefour EH, Janssens G, Smeets J, et al
    Prompt Gamma Imaging for In Vivo Range Verification of Pencil Beam Scanning Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:210-218.
    PubMed     Text format     Abstract available


    J Neurochem

  13. AHMAD F, Patrick S, Sheikh T, Sharma V, et al
    TERT-EZH2 network regulates lipid metabolism and DNA damage responses in glioblastoma.
    J Neurochem. 2017 Aug 21. doi: 10.1111/jnc.14152.
    PubMed     Text format     Abstract available


    J Neurooncol

  14. FRINTON E, Tong D, Tan J, Read G, et al
    Metastatic melanoma: prognostic factors and survival in patients with brain metastases.
    J Neurooncol. 2017 Aug 17. doi: 10.1007/s11060-017-2591.
    PubMed     Text format     Abstract available

  15. JIAO JT, Sun J, Ma JF, Dai MC, et al
    Retraction Note to: Relationship between inflammatory cytokines and risk of depression, and effect of depression on the prognosis of high grade glioma patients.
    J Neurooncol. 2017;134:475.
    PubMed     Text format    

  16. FORTIN D, Tsang D, Ng A, Laperriere N, et al
    Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.
    J Neurooncol. 2017 Aug 19. doi: 10.1007/s11060-017-2597.
    PubMed     Text format     Abstract available

  17. KHANNA V, Achey RL, Ostrom QT, Block-Beach H, et al
    Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.
    J Neurooncol. 2017 Aug 21. doi: 10.1007/s11060-017-2594.
    PubMed     Text format     Abstract available

  18. AYALA-PEACOCK DN, Attia A, Braunstein SE, Ahluwalia MS, et al
    Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram.
    J Neurooncol. 2017 Aug 21. doi: 10.1007/s11060-017-2588.
    PubMed     Text format     Abstract available

  19. YOULAND RS, Kreofsky CR, Schomas DA, Brown PD, et al
    The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma.
    J Neurooncol. 2017 Aug 23. doi: 10.1007/s11060-017-2599.
    PubMed     Text format     Abstract available

  20. KOSHY M, Sher DJ, Spiotto M, Husain Z, et al
    Association between hospital volume and receipt of treatment and survival in patients with glioblastoma.
    J Neurooncol. 2017 Aug 23. doi: 10.1007/s11060-017-2598.
    PubMed     Text format     Abstract available


    J Neurosurg

  21. KALOSHI G, Petrela M
    Letter to the Editor. An extent of resection threshold for recurrent glioblastoma: why wait until recurrence?
    J Neurosurg. 2017 Aug 18:1. doi: 10.3171/2017.6.JNS14868.
    PubMed     Text format    

  22. BRAGSTAD S, Flatebo M, Natvig GK, Eide GE, et al
    Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    J Neurosurg. 2017 Aug 18:1-13. doi: 10.3171/2017.2.JNS161659.
    PubMed     Text format     Abstract available

  23. HUA L, Zhu H, Li J, Tang H, et al
    Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
    J Neurosurg. 2017 Aug 18:1-9. doi: 10.3171/2017.2.JNS162566.
    PubMed     Text format     Abstract available

  24. ZUBATKINA I, Ivanov P
    Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis.
    J Neurosurg. 2017 Aug 25:1-12. doi: 10.3171/2017.1.JNS162075.
    PubMed     Text format     Abstract available


    J Nucl Med

  25. VELDHUIJZEN VAN ZANTEN SEM, Sewing ACP, van Lingen A, Hoekstra OS, et al
    Multiregional tumor drug-uptake imaging by PET and microvascular morphology in end-stage diffuse intrinsic pontine glioma.
    J Nucl Med. 2017 Aug 17. pii: jnumed.117.197897. doi: 10.2967/jnumed.117.197897.
    PubMed     Text format     Abstract available


    JAMA

  26. SLOMSKI A
    Stereotactic Radiotherapy Is Superior for Benign Brain Tumors.
    JAMA. 2017;318:690.
    PubMed     Text format    


    Neuro Oncol

  27. GOERIG NL, Frey B, Uberla K, Gaipl U, et al
    A clinician's plea to test glioma patients for CMV.
    Neuro Oncol. 2017;19:1282-1283.
    PubMed     Text format    

  28. SCHNEIDER M, Reitter EM, Kastner MT, Thannesberger J, et al
    Absence of CMV viremia in high-grade glioma patients under low dosage glucocorticoid treatment.
    Neuro Oncol. 2017;19:1280-1282.
    PubMed     Text format    

  29. COONEY T, Lane A, Bartels U, Bouffet E, et al
    Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study.
    Neuro Oncol. 2017;19:1279-1280.
    PubMed     Text format    

  30. BALASUBRAMANIYAN V, Bhat KP
    Targeting MIR155HG in glioma: a novel approach.
    Neuro Oncol. 2017;19:1152-1153.
    PubMed     Text format    


    PLoS One

  31. SCRIBNER E, Fathallah-Shaykh HM
    Single Cell Mathematical Model Successfully Replicates Key Features of GBM: Go-Or-Grow Is Not Necessary.
    PLoS One. 2017;12:e0169434.
    PubMed     Text format     Abstract available

  32. MARIGIL M, Martinez-Velez N, Dominguez PD, Idoate MA, et al
    Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System.
    PLoS One. 2017;12:e0170501.
    PubMed     Text format     Abstract available

  33. RAMIS R, Tamayo-Uria I, Gomez-Barroso D, Lopez-Abente G, et al
    Risk factors for central nervous system tumors in children: New findings from a case-control study.
    PLoS One. 2017;12:e0171881.
    PubMed     Text format     Abstract available

  34. GAO B, Shen X, Shiroishi MS, Pang M, et al
    A pilot study of pre-operative motor dysfunction from gliomas in the region of corticospinal tract: Evaluation with diffusion tensor imaging.
    PLoS One. 2017;12:e0182795.
    PubMed     Text format     Abstract available

  35. GAO L, Chen B, Li J, Yang F, et al
    Wnt/beta-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms.
    PLoS One. 2017;12:e0181346.
    PubMed     Text format     Abstract available

  36. ROSAGER AM, Sorensen MD, Dahlrot RH, Hansen S, et al
    Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
    PLoS One. 2017;12:e0182954.
    PubMed     Text format     Abstract available

  37. CHIBA R, Akiya M, Hashimura M, Oguri Y, et al
    ALK signaling cascade confers multiple advantages to glioblastoma cells through neovascularization and cell proliferation.
    PLoS One. 2017;12:e0183516.
    PubMed     Text format     Abstract available

  38. SCHOB S, Meyer J, Gawlitza M, Frydrychowicz C, et al
    Diffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma.
    PLoS One. 2016;11:e0161386.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: